(-0.07%) 5 096.61 points
(0.09%) 38 275 points
(-0.09%) 15 914 points
(-1.38%) $82.69
(5.82%) $2.04
(0.25%) $2 353.00
(-0.22%) $27.48
(3.80%) $957.15
(-0.20%) $0.933
(-0.29%) $10.99
(-0.50%) $0.796
(1.74%) $93.47
0.00% $ 7.87
Live Chart Being Loaded With Signals
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases...
Stats | |
---|---|
Tagesvolumen | 78 963.00 |
Durchschnittsvolumen | 74 175.00 |
Marktkapitalisierung | 239.65M |
EPS | $-0.420 ( 2024-03-13 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-08 |
Last Dividend | $2.50 ( 2021-07-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.72 |
ATR14 | $0.0350 (0.44%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-03 | Simard John | Buy | 2 470 355 | Convertible Loan Agreement |
2023-06-23 | Waldin Jan-paul | Buy | 25 000 | Director Stock Option |
2023-06-23 | Libby Peter | Buy | 25 000 | Director Stock Option |
2023-06-23 | Macadam Donald H. | Buy | 25 000 | Director Stock Option |
2023-06-23 | Mckenzie W Thorpe | Buy | 25 000 | Director Stock Option |
INSIDER POWER |
---|
97.98 |
Last 100 transactions |
Buy: 4 116 188 | Sell: 11 979 897 |
Volumen Korrelation
XBiotech Inc Korrelation
10 Am meisten positiv korreliert | |
---|---|
VVOS | 0.88 |
BPRN | 0.871 |
BELFA | 0.856 |
CGO | 0.845 |
CNTY | 0.845 |
PASG | 0.84 |
APLD | 0.838 |
DORM | 0.831 |
BBCP | 0.815 |
ATNX | 0.812 |
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
XBiotech Inc Korrelation - Währung/Rohstoff
XBiotech Inc Finanzdaten
Annual | 2023 |
Umsatz: | $0 |
Bruttogewinn: | $-1.74M (0.00 %) |
EPS: | $-0.810 |
FY | 2023 |
Umsatz: | $0 |
Bruttogewinn: | $-1.74M (0.00 %) |
EPS: | $-0.810 |
FY | 2022 |
Umsatz: | $4.01M |
Bruttogewinn: | $3.36M (83.77 %) |
EPS: | $-1.080 |
FY | 2021 |
Umsatz: | $18.39M |
Bruttogewinn: | $12.57M (68.36 %) |
EPS: | $-0.580 |
Financial Reports:
No articles found.
XBiotech Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $2.50 | 2021-07-15 |
Last Dividend | $2.50 | 2021-07-15 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-23 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $2.50 | -- |
Avg. Dividend % Per Year | 1.55% | -- |
Score | 0.63 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 0 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2021 | $2.50 | 15.50% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -9.37 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.108 | 1.200 | -3.60 | -4.32 | [0 - 0.3] |
returnOnEquityTTM | -0.108 | 1.500 | -2.31 | -3.47 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 33.07 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 32.94 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 32.79 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.615 | 2.00 | -0.205 | -0.410 | [0 - 30] |
freeCashFlowPerShareTTM | -0.627 | 2.00 | -0.314 | -0.627 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.334 | 1.000 | 7.76 | 7.76 | [0.2 - 0.8] |
operatingProfitMarginTTM | -14.32 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.0115 | 0.800 | -3.26 | -2.61 | [0.5 - 2] |
Total Score | -0.390 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -9.75 | 1.000 | -1.086 | 0 | [1 - 100] |
returnOnEquityTTM | -0.108 | 2.50 | -1.487 | -3.47 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.627 | 2.00 | -0.209 | -0.627 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.615 | 2.00 | -0.205 | -0.410 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.275 | 1.500 | -5.17 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -7.15 | 1.000 | -10.00 | 0 | [0.1 - 0.5] |
Total Score | -2.34 |
XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.